Concentriq AP-Dx logo

Concentriq AP-Dx

Digital pathology imaging and interpretation for primary diagnosis, enabling pathologists to view, analyze, and collaborate on whole slide images in clinical settings.

Solution by Proscia Inc.
Visit website
AI-generated from publicly available materials.

Overview

Concentriq AP-Dx is a comprehensive digital pathology software platform developed by Proscia, designed to support primary diagnosis in clinical settings of all sizes — from individual reference laboratories to large, multi-site hospital systems. The platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the purpose of primary diagnosis, and has been rated #1 by customers in the 2026 KLAS Digital Pathology rankings in both Europe and the United States, with 100% of surveyed customers stating they would buy again.

Built with a pathologist-centric design philosophy, Concentriq AP-Dx immerses pathologists in an intuitive experience for viewing, interpreting, sharing, and managing whole slide images. The platform is engineered to help labs transition confidently from glass slides to a fully digital diagnostic workflow, driving measurable gains in quality, efficiency, and readiness for future growth.

Core Capabilities

  • FDA 510(k)-cleared solution (K230839) for primary diagnosis in anatomic pathology
  • High-performance whole slide image viewer with tools designed to ease the transition from glass to digital
  • Real-time collaboration features enabling pathologists to share cases and broaden access to specialist expertise across sites
  • Robust interoperability to support large, multi-site organizations and integrate with existing laboratory infrastructure
  • Pathologist-centric workflows purpose-built for the modern anatomic pathology lab

AI-Powered Diagnostic Workflows

  • Deep integration with AI-powered diagnostic tools, enabling advanced computational pathology at scale
  • Demonstrated real-world impact in a feasibility study conducted with Quest Diagnostics and Ibex Medical Analytics, where AI-powered workflows allowed pathologists to sign out 2.9 cases per hour compared to 1.2 cases per hour without AI assistance
  • Supports the broader laboratory vision of embracing digitization and AI to overcome systemic challenges and advance precision medicine

Deployment and Professional Services

  • Suitable for clinical environments ranging from individual reference laboratories to the largest health systems
  • Proscia provides professional services alongside the software platform to support labs through every stage of their digital transformation
  • Positioned to support labs seeking to improve diagnostic quality, operational efficiency, and long-term scalability

Concentriq AP-Dx is part of the broader Concentriq Enterprise Pathology Platform offered by Proscia, which also includes an AI Portfolio and Proscia Aperture. The platform is designed for organizations committed to a digital and computational future in pathology, with a focus on interoperability, proven clinical workflows, and seamless integration of AI-driven capabilities.

Meta

Domain
Digital Pathology & Imaging
Subdomain
Digital Pathology Analysis
Software type(s)
Analytical Platform
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
Academic / ResearchBiotechCRODiagnostics / IVDPharma
Development stage(s)
Clinical
Target user(s)
Lab Manager / Core Facility ManagerClinical / Diagnostic Professional
Compliance standard(s)
21 CFR Part 11
Tag(s)
Uses AI